1-2 of 2
Keywords: Lymphokine-activated killer
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Localization of LAK Cells and IL-2-Stimulated Regional Lymph Node Lymphocytes by Regional Arterial Infusion in Renal Tumor-Bearing Rats

Available to Purchase
Subject Area:
Further Areas
Masamichi Hayakawa, David M. Lubaroff, Richard D. Williams, Akira Osawa
Journal: Urologia Internationalis
Urol Int (1993) 50 (4): 185–191.
https://doi.org/10.1159/000282481
Published Online: 03 February 2010
...Masamichi Hayakawa; David M. Lubaroff; Richard D. Williams; Akira Osawa We describe the results of a traffic assay of the regional arterial administration of either lymphokine-activated killer cells or recombinant interleukin-2-acti-vated regional lymph node lymphocytes in tumor-bearing rats...
View article titled, Localization of LAK Cells and IL-2-Stimulated Regional Lymph Node Lymphocytes by Regional Arterial Infusion in Renal Tumor-Bearing Rats
Open the PDF for Localization of LAK Cells and IL-2-Stimulated Regional Lymph Node Lymphocytes by Regional Arterial Infusion in Renal Tumor-Bearing Rats in another window
Journal Articles

Treatment of Advanced Renal Cell Carcinoma Using Regional Arterial Administration of Lymphokine-Activated Killer Cells in Combination with Low Doses of rlL-2

Available to Purchase
Subject Area:
Further Areas
Masamichi Hayakawa, Tadashi Hatano, Yoshihide Ogawa, Munehisa Gakiya, Hideaki Ogura, Akira Osawa
Journal: Urologia Internationalis
Urol Int (1994) 53 (3): 117–124.
https://doi.org/10.1159/000282651
Published Online: 03 February 2010
...Masamichi Hayakawa; Tadashi Hatano; Yoshihide Ogawa; Munehisa Gakiya; Hideaki Ogura; Akira Osawa We investigated the usefullness and problems of arterial administration of lymphokine activated killer (LAK) cells in combination with systemic IL-2 in the treatment of metastatic renal cell carcinoma...
View article titled, Treatment of Advanced Renal Cell Carcinoma Using Regional Arterial Administration of Lymphokine-Activated Killer Cells in Combination with Low Doses of rlL-2
Open the PDF for Treatment of Advanced Renal Cell Carcinoma Using Regional Arterial Administration of Lymphokine-Activated Killer Cells in Combination with Low Doses of rlL-2 in another window